Advertisement
Organisation › Details
Wales Life Sciences Investment Fund (WLSIF)
The Wales Life Sciences Investment Fund is a key part of the Welsh Government’s Life Sciences initiative, as outlined by the Minister for Business, Enterprise, Technology and Science Edwina Hart. The Fund invests in Life Sciences and related medical, pharmaceutical and healthcare companies currently based in Wales, and also in companies from across the UK, Europe and the rest of the world, where such investment will bring meaningful developmental and economic benefit to Wales. *
Start | 2013-03-19 start | |
Group | Arix Bioscience (Group) | |
Industry | venture capital | |
Person | Evans, Christopher (Chris) (Arthurian Life Sciences + Merlin Biosciences + Chiroscience + Celsis + Enzymatix) | |
Person 2 | Curnock-Cook, Jeremy (Bioscience Managers 200506) | |
Region | Cardiff | |
Country | United Kingdom (GB) | |
Street | 1 Callaghan Square | |
City | CF10 5BT Cardiff, Wales | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
Currency | GBP | |
Annual sales | 100,000,000 (fund size, targeted 2014-03-08) | |
* Document for »About Section«: | ||
Record changed: 2018-10-31 |
Advertisement
More documents for Arix Bioscience (Group)
- [1] Evommune, Inc.. (4/26/23). "Press Release: Evommune Closes $50 Million Series B Financing to Advance Broad Pipeline of Therapies to Treat Chronic Inflammatory Diseases". Palo Alto, CA....
- [2] UCB S.A.. (3/9/23). "Press Release: UCB’s Board of Directors Appoints Jonathan Peacock as New Chair". Brussels....
- [3] Arix Bioscience plc. (12/22/21). "Press Release: Arix Bioscience Co-leads $31 Million Series A Financing for New Portfolio Company Sorriso Pharmaceuticals". London....
- [4] Sorriso Pharmaceuticals, Inc.. (12/22/21). "Press Release: Sorriso Pharmaceuticals Launches with $31 Million to Develop Novel Class of Orally Delivered Cytokine Antibodies to Treat Inflammatory Conditions". Salt Lake City, UT....
- [5] Rentschler Biopharma SE. (9/20/21). "Press Release: Rentschler Biopharma Appoints Dr. Christian Schetter as Chief Scientific Officer, Strengthening Scientific Focus". Laupheim & Milford, MA....
- [6] Pyxis Oncology, Inc.. (3/30/21). "Press Release: Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics". Cambridge, MA....
- [7] Arix Bioscience plc. (3/24/21). "Press Release: Strategy Implementation Review". London....
- [8] Arix Bioscience plc. (11/5/20). "Press Release: VelosBio to Be Acquired by Merck for $2.75 Billion". London....
- [9] GenSight Biologics S.A.. (10/22/20). "Press Release: GenSight Biologics Successfully Raises €25 Million in an Oversubscribed Private Placement With US and European Institutional Investors". Paris....
- [10] VelosBio Inc.. (7/8/20). "Press Release: VelosBio Raises $137 Million in Series B Financing to Advance Development of ROR1-Directed Therapeutics in Oncology"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top